About SABiosciences
SABiosciences is a company based in Frederick (United States) founded in 1998 by Li Shen was acquired by Qiagen in November 2009. SABiosciences offers products and services including QIAcuityDx, QIAwave Kits, Proteinase K, and TissueLyser III. SABiosciences operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Frederick, United States
- Founders Li Shen
- SectorsHealthcare
- Website sabiosciences.com
- Social LinkedIn
- Acquired by Qiagen (Nov 2009)
Products & Services of SABiosciences
SABiosciences offers a comprehensive portfolio of products and services, including QIAcuityDx, QIAwave Kits, Proteinase K, and TissueLyser III.
Automated tool for precise detection and quantification of genetic variations.
Eco-friendly kits for sustainable extraction of DNA and RNA samples.
Efficient enzyme for protein digestion in biological sample preparation.
Instrument for effective lysis of challenging samples for analysis.
Investors in SABiosciences
SABiosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Products and reagents for molecular diagnostic assays are supplied. | 1984 | qiagen.com | Hilden, Germany |
Investor details for SABiosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SABiosciences
2 people are tracked at SABiosciences (2 in leadership).
| Name | Role | Group |
|---|---|---|
Li Shen | Co-Founder | Leadership |
Peer Schatz | CEO | Leadership |
Complete people profiles for SABiosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SABiosciences
2 dated milestones of SABiosciences across 11 years, from founding to its latest funding, stage changes and deals.
- Founded SABiosciences is founded.
- Exit Acquired by Qiagen.
Competitors of SABiosciences
SABiosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | |
| exonhit.com | 1997 | Paris, France | $65.46M | – | Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits |
Detailed competitors of SABiosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SABiosciences
Websites that share an audience with SABiosciences (sabiosciences.com).
Websites whose visitors overlap most with SABiosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qiagen.com | 100% | 458.2K | #105,023 | View details | |
| rndsystems.com | 96% | 349K | #159,292 | View details | |
promega.com | promega.com | 86% | – | #192,389 | β |
| systembio.com | 85% | 23.8K | #1,129,361 | View details | |
| jacksonimmuno.com | 71% | – | #680,486 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 18 similar websites and full traffic analytics for SABiosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to SABiosciences
10 companies that operate in the same segment as SABiosciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SABiosciences
SABiosciences was founded in 1998.
SABiosciences is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
Peer Schatz is the current CEO of SABiosciences.
SABiosciences designs, develops, manufactures, and commercializes disease- and pathway-focused real-time PCR-based assay panels, which are used in biomedical research, as well as in the development of drugs and diagnostics. It offers real-time PCR assay panels designed for analysis of DNA, RNA, epigenetic, and microRNA targets in biological pathways associated with specific diseases, such as cancer, diabetes, immune, and cardiovascular disorders, as well as with pathways, such as apoptosis, signal transduction, and toxicology. The companys products also include SureSilencing, which are RNA interference shRNA plasmids; ELISArray kits to monitor multiple cytokines and chemokines simultaneously; EpiTect ChIP qPCR System, which provides a platform for the in vivo analysis of the interaction between DNA and nuclear proteins; EpiTect ChIP PCR array, which is a panel of primer assays for pathway or disease-focused genes; EpiTect Methyl II PCR system, a technology enabling the detection of CpG island DNA methylation of individual genes, as well as diseases or pathways focused gene panels without bisulfite modification; and PCR reagent kits, PCR array data analysis software, PCR array data analysis quick reference cards, and instrument setup instructions. In addition, the company provides services for genomic and expression analysis. SABiosciences Corporation was formerly known as SuperArray Bioscience Corporation and changed its name to SABiosciences Corporation in July 2008. The company was founded in 1998 and is based in Frederick, Maryland. As of December 14, 2009, SABiosciences Corporation operates as a subsidiary of Qiagen NV.
SABiosciences's top competitors include Abcam, Sino Biological and Meridian Bioscience.
SABiosciences offers QIAcuityDx, QIAwave Kits, Proteinase K, and TissueLyser III.
SABiosciences has 1 investor. Key investors include Qiagen.
Yes. SABiosciences was acquired by Qiagen in November 2009.
